JPH0414583B2 - - Google Patents

Info

Publication number
JPH0414583B2
JPH0414583B2 JP60231998A JP23199885A JPH0414583B2 JP H0414583 B2 JPH0414583 B2 JP H0414583B2 JP 60231998 A JP60231998 A JP 60231998A JP 23199885 A JP23199885 A JP 23199885A JP H0414583 B2 JPH0414583 B2 JP H0414583B2
Authority
JP
Japan
Prior art keywords
agent
acid
weight
cooh
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60231998A
Other languages
Japanese (ja)
Other versions
JPS6291447A (en
Inventor
Kazuhiro Ono
Mutsumi Shibuya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Showa Yakuhin Kako Co Ltd
Original Assignee
Showa Yakuhin Kako Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Yakuhin Kako Co Ltd filed Critical Showa Yakuhin Kako Co Ltd
Priority to JP60231998A priority Critical patent/JPS6291447A/en
Publication of JPS6291447A publication Critical patent/JPS6291447A/en
Publication of JPH0414583B2 publication Critical patent/JPH0414583B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明は軟組織、歯肉或いは歯質に粘着し易
く、セメント化し、長期間崩壊又は脱落しないこ
とを特徴とするセメント組成物に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a cement composition that is characterized by being easy to adhere to soft tissue, gingiva or tooth substance, cementing, and not disintegrating or falling off for a long period of time.

従来の技術 口腔又は歯科領域におけるのみならず外科、成
形外科、獣医科において創傷面包帯剤として従来
から各種のセメント製剤が用いられ、市販されて
いる。これらの多くは酸化亜鉛とユージノールと
を基本材料とし、該セメントの強化剤としてはア
スベスト繊維が使用されている。アスベスト繊維
は酸化亜鉛及びユージノールとのなじみが良くこ
れらの諸材料の練和物の手掌上でのベトつきを抑
える作用があると言われている。この性質を利用
した市販品が製剤化されている。
BACKGROUND OF THE INVENTION Various cement preparations have been used as wound dressings not only in the oral cavity or dental field but also in surgery, plastic surgery, and veterinary medicine, and are commercially available. Most of these have zinc oxide and eugenol as basic materials, and asbestos fibers are used as reinforcing agents for the cement. It is said that asbestos fibers have good compatibility with zinc oxide and eugenol, and have the effect of suppressing the stickiness of a mixture of these materials on the palm of the hand. Commercially available products have been formulated that take advantage of this property.

口腔内の観血的手術は成形外科、口腔外科、歯
科の分野で日常数多く行なわれている。一例を上
げれば成形外科では口蓋の奇形の手術、口腔外科
では口腔内癌組織の適除術、顎骨に達するような
手術、歯科では矯正術、歯肉切除術、歯石除去、
抜歯などがある。
Open oral surgery is routinely performed in the fields of plastic surgery, oral surgery, and dentistry. For example, in plastic surgery, surgery for palate deformities, in oral surgery, appropriate removal of cancerous tissue in the oral cavity, surgery that reaches the jawbone, in dentistry, orthodontics, gingivectomy, tartar removal, etc.
This includes tooth extraction.

口腔はその生活機能から云つて常に唾液で濡れ
ており、食物を噛み砕き、会話をする重要な器官
であつて更に多種多量の細菌が常在する。かよう
な部位の術後には例えば抜歯後の創傷面のように
綿球で圧迫させて止血し、自然治癒させる場合も
あれば、歯石除去後の創傷面のようにヨード剤の
ような消毒薬を用いて貼薬して患者を帰宅させる
場合もある。しかし創傷面が大きく深い時で、し
かも通常の生活を営みながら創傷面の回復を計る
場合などには口腔内で固化する特別なセメントが
使われることが多い。
Due to its daily functions, the oral cavity is constantly wet with saliva, and is an important organ for chewing food and having conversations, and is home to a wide variety of bacteria. After surgery in such areas, for example, the wound surface after a tooth extraction may be compressed with a cotton ball to stop the bleeding and heal naturally, or the wound surface may be disinfected with iodine, such as on the wound surface after removing tartar. In some cases, patients are sent home with medication. However, when the wound surface is large and deep, and when the wound surface is to be recovered while the patient continues to lead a normal life, a special cement that hardens in the oral cavity is often used.

このセメントは施用時には粘土のように軟らか
く可塑性があり、口腔内では水分と温度とで硬化
反応が加速され数分で固化し、創傷面を覆い包
む。このセメントをパツク剤とか包帯剤とか称す
る。このようなパツク用セメントの好適な一例が
サーヂカルパツク「昭和」(商標名)(昭和薬品化
工KK製)であつて該パツクは粉末と液剤とが組
になつており、粉末は酸化亜鉛を主体とし、液剤
はユージノール(オイゲノール)を主体とするい
わする酸化亜鉛ユージノールセメントの一種であ
る。該パツクの特徴は粉末の方に処方されたアス
ベスト繊維にあり、該繊維は練和から施用に至る
までの取扱い操作上に不可欠の成分であり、か
つ、セメントが硬化した後にはセメントの実質を
つなぐ「つなぎ材」の役目を持ち、口腔内で強靱
性を保持し開放創傷面が治癒するまで破断される
ことなく包帯剤として患者を覆う役目を担う。
When applied, this cement is soft and plastic like clay, and in the oral cavity, the hardening reaction is accelerated by moisture and temperature, solidifying in a few minutes and covering the wound surface. This cement is called a pack or bandage. A suitable example of such cement for packs is the surgical pack "Showa" (trade name) (manufactured by Showa Yakuhin Kako KK), which is a combination of powder and liquid, and the powder is mainly composed of zinc oxide. The liquid agent is a type of zinc oxide eugenol cement, which is mainly composed of eugenol. The characteristic of this pack lies in the asbestos fiber that is formulated into the powder.The fiber is an essential ingredient in handling operations from mixing to application. It has the role of a ``tethering material,'' which maintains its toughness within the oral cavity and serves to cover the patient as a bandage without breaking until the open wound surface has healed.

上述のアスベスト繊維の役目である操作性と靱
性との賦与のうち後者は他の繊維即ち綿、ナイロ
ン、ビニロン、アクリル等いずれでも或程度の代
用が可能であるが、前者の操作性は微妙な感触の
問題であつて、従来はアスベストでなければ達成
されないものとされていた。
Of the above-mentioned roles of asbestos fibers, which are to impart operability and toughness, the latter can be substituted to some extent with other fibers such as cotton, nylon, vinylon, acrylic, etc., but the operability of the former is delicate. This is a matter of feel, and until now it was thought that this could only be achieved using asbestos.

該操作性を説明すれば、術者が先ず粉末と液剤
との適量を採りスパチユラで練和してペーストを
作り該ペーストをスパチユラで転がし、伸ばして
径5mm、長さ4cm位の円柱状にする。この操作で
アスベストを配合していないと円柱状にならず、
該ペーストはスパチユラや練合板にベタベタくつ
つき取扱いにくい。次に術者は円柱状とした該練
和物を指でつまみ、口腔内の創傷面に当て、指先
で平らに伸ばして創傷面の上を完全に覆う。術者
が指で練和物を取扱うときにベタベタと手指に粘
着したのでは創傷面に練和物を貼着させることが
困難である。このように術者の使いやすい包帯
剤、即ち操作性のよい包帯剤はアスベストの配合
により達せられることが知られており、又アスベ
スト以外の繊維ではこの操作性を代行せしめるこ
とが出来ないものとされて来た。
To explain the operability, the operator first takes an appropriate amount of powder and liquid, mixes them with a spatula to make a paste, rolls the paste with a spatula, and stretches it into a cylinder with a diameter of 5 mm and a length of about 4 cm. . If asbestos is not mixed in this operation, it will not become cylindrical,
The paste is sticky to the spatula or kneading board and difficult to handle. Next, the operator picks up the cylindrical mixture with his fingers, applies it to the wound surface in the oral cavity, and stretches it flat with his fingertips to completely cover the wound surface. When the operator handles the mixture with his/her fingers, it is difficult to adhere the mixture to the wound surface if the mixture becomes sticky on the fingers. It is known that a dressing that is easy for the operator to use, that is, a dressing that has good operability, can be achieved by incorporating asbestos, and it is not possible to achieve this operability with fibers other than asbestos. I've been

発明が解決しようとする問題点 しかるに近時アスベストが人体に悪影響を与え
ることが問題になり従つてこれに代るものが要望
されると同時に従来以上に口腔軟組織及び歯質並
びにその他の組織の表面への附着性の向上及び長
時間の局所滞留性の改善が求められている。
Problems to be Solved by the Invention However, in recent years, it has become a problem that asbestos has an adverse effect on the human body.Therefore, there is a demand for a substitute for asbestos, and at the same time, the surface of oral soft tissues, teeth, and other tissues is becoming more important than ever. There is a need for improved adhesion to and long-term local retention.

問題点を解決するための手段 本発明に従えば上記の諸点に鑑みより改善され
たセメント組成物を得るために従来のセメント組
成物中のアスベストをパルプ繊維で代替して混和
し、さらにカルボキシビニルポリマー(以下
CVPと略記)を混合する。かようにして得られ
る新規なセメント組成物は歯肉或いは歯質に粘着
し易く、しかも従来以上に局所滞留性が長時間に
延長され、脱落又は崩壊し難いものであると同時
にその製造が容易でコストも低いので組織表面及
び創傷面に対する包帯剤として最適である。
Means for Solving the Problems According to the present invention, in view of the above points, in order to obtain an improved cement composition, asbestos in the conventional cement composition is substituted and mixed with pulp fiber, and carboxyvinyl Polymer (hereinafter
(abbreviated as CVP). The novel cement composition obtained in this manner easily adheres to the gums or tooth structure, has a longer local retention than before, is difficult to fall off or disintegrate, and is easy to manufacture. Due to its low cost, it is ideal as a dressing for tissue and wound surfaces.

本発明の特徴は従来から知られている酸化亜
鉛、ユージノール、アスベスト繊維、及び有機飽
和脂肪酸又は有機不飽和脂肪酸で構成されるセメ
ント組成物中のアスベスト繊維の代りにパルプ繊
維を混和し、さらに軟組織及び歯質又は創傷の表
面への付着性、施用後の早期の脱落並びにセメン
ト実質の崩壊性を改善するためにCVPを混合す
ることにある。アスベストを加えないで製した酸
化亜鉛とユージノールとからなるセンメント組成
物はこれを創傷面包帯剤として使用すると練和物
は手指にベタベタ粘着するため該練和物を手掌上
でダンゴ状にまるめる際に非常な困難を伴なうな
どの欠点をもつ。
The characteristics of the present invention are that pulp fibers are mixed in place of asbestos fibers in the conventionally known cement composition composed of zinc oxide, eugenol, asbestos fibers, and organic saturated fatty acids or organic unsaturated fatty acids; and mixing CVP to improve adhesion to tooth or wound surfaces, early shedding after application, and disintegration of cement parenchyma. When a cement composition made of zinc oxide and eugenol made without asbestos is used as a wound dressing, the mixture becomes sticky on the hands and fingers, so it is difficult to roll the mixture into a ball shape on the palm of the hand. It has disadvantages such as great difficulty.

本発明では酸化亜鉛を主体とするA剤と、ユー
ジノール又は有機酸を含有するB剤とからなり、
使用時にA剤及びB剤を適量混和して患部に施用
するが繊維は通常A剤中に処方されるので、先
ず、本発明においてもA剤について検討した。そ
の結果該セメント組成物のA剤中の従来のアスベ
ストの代りにパルプ繊維を混和すると該セメント
硬化物(以下セメント体と略記する)の強度を向
上し併せてCVPの添加混合により該セメント体
の組織又は歯肉の表面への粘着性が向上し、該セ
メント体の脱落及び崩壊が著しく改善され長期間
の使用が可能となつた。
The present invention consists of an agent A mainly containing zinc oxide and an agent B containing eugenol or an organic acid.
At the time of use, appropriate amounts of Agents A and B are mixed and applied to the affected area, and since fibers are usually formulated in Agent A, Agent A was first studied in the present invention. As a result, when pulp fiber is mixed in place of the conventional asbestos in the A component of the cement composition, the strength of the cement hardened product (hereinafter abbreviated as cement body) is improved, and the addition and mixing of CVP improves the strength of the cement body. The adhesion to the tissue or gingival surface was improved, and the shedding and disintegration of the cement body were significantly improved, making it possible to use it for a long period of time.

この場合にはパルプ繊維の代りに他の繊維とし
てナイロン、ビニロン、又はテトロン繊維を使用
したがパルプ繊維程の効果を達成することができ
なかつた。これはパルプ繊維が綿繊維を切断して
製造されたものでありまた繊維構成分のグルコー
ス分子面の遊離の−OH基及び−CHO基等の親水
性基の存在のため該B剤との親和性と同時に該B
剤に対して繊維のもつ物理的な保持性を呈するの
でこれらの性質がセメント練和物の靱性の確保及
び術者の手指にベタベタ付着しないという特性に
寄与していると考える。
In this case, other fibers such as nylon, vinylon, or tetron fibers were used in place of pulp fibers, but they were not able to achieve the same effect as pulp fibers. This is because the pulp fibers are manufactured by cutting cotton fibers, and because of the presence of hydrophilic groups such as free -OH groups and -CHO groups on the glucose molecule surface of the fiber components, it has an affinity with the B agent. B at the same time as sex
It is believed that these properties contribute to ensuring the toughness of the cement mixture and ensuring that it does not stick to the surgeon's fingers because the fibers exhibit physical retention properties for the agent.

また他方CVPについてはこのものは前記の通
りアクリル酸とアルリ化多価アルコールとの共重
合によつて得られた水溶性高分子であり従来から
化粧品及び医薬品等の増粘剤又は分散安定剤とし
て知られているが歯科等のセメント組成物に使用
された例は本発明以前にない。例えば水溶性高分
子としてメチルセルローズ、アラビアゴム、ポリ
ビニルピロリドン又はオポリエチレンオキサイド
等をCVPの代りに試用したがCVP程の効果は得
られなかつた。これはCVPは分子内のOH基及び
COOH基の存在により該セメント組成物中の強
力な界面活性剤として作用し従つて該組成物相互
の親和性を増すと共に唾液と遭遇し、セメント体
表面の粘性を増し生体組織との親和性を向上させ
る結果として組織表面或は歯質又は歯肉表面に体
する粘着力を増し、該パルプ繊維の作用と相俟つ
て該セメント体の特性を改善向上せしめるのであ
ると考えられる。
On the other hand, as mentioned above, CVP is a water-soluble polymer obtained by copolymerizing acrylic acid and allylated polyhydric alcohol, and has been used as a thickener or dispersion stabilizer for cosmetics and pharmaceuticals. Although known, there have been no examples of its use in cement compositions for dentistry or the like prior to the present invention. For example, water-soluble polymers such as methylcellulose, gum arabic, polyvinylpyrrolidone, and opolyethylene oxide were tried in place of CVP, but they were not as effective as CVP. This is because CVP has an OH group in the molecule and
The presence of COOH groups acts as a strong surfactant in the cement composition, thus increasing the mutual affinity of the composition, and upon encountering saliva, increases the viscosity of the surface of the cement and improves the affinity with living tissue. It is thought that as a result of this improvement, the adhesion to the tissue surface, tooth substance, or gingival surface is increased, and together with the action of the pulp fibers, the properties of the cement body are improved.

更にCVPに代用し得られるものについて種々
研究の結果パルミチン酸及びステアリン酸等の有
機脂肪酸がCVPに近い効果を示すことを見出し
た。本発明においてCVPの代替物として又は
CVPとの併用物としてのA剤中の有機脂肪酸は
ラウリン酸、ミリスチン酸、パルミチン酸又はス
テアリン酸で、常温で固型の脂肪酸である。これ
らの有機脂肪酸は分子中に−COOH基を持つて
おり、この点はCVPが分子に−COOH基を有す
るのと共通である。有機脂肪酸の−CH2−は疎水
性であるが、−COOH基は親水性であり、該セメ
ント体表面と生体組織との親和性を増すために、
結果としてCVPを用いたと同様に該セメント体
の特性を改善向上せしめるのであると考えられ
る。
Furthermore, as a result of various studies on substitutes for CVP, it has been found that organic fatty acids such as palmitic acid and stearic acid exhibit effects similar to those of CVP. In the present invention, as a substitute for CVP or
The organic fatty acids in Part A used in combination with CVP are lauric acid, myristic acid, palmitic acid, or stearic acid, which are solid fatty acids at room temperature. These organic fatty acids have a -COOH group in their molecules, which is common to CVP, which has a -COOH group in its molecules. -CH 2 - of organic fatty acids is hydrophobic, but -COOH group is hydrophilic, and in order to increase the affinity between the surface of the cement body and biological tissue,
As a result, it is thought that the properties of the cement body are improved in the same way as when CVP is used.

なおまたパルプ繊維は該セメント組成物のA剤
中2〜7重量%混和されることが望ましく、又
CVP及び(又は)有機脂肪酸は該セメント組成
物中のA剤中0.1〜3.0重量%の量で混合されるこ
とが好ましい。
Furthermore, it is desirable that the pulp fiber be mixed in an amount of 2 to 7% by weight in the A agent of the cement composition, and
CVP and/or organic fatty acids are preferably mixed in an amount of 0.1 to 3.0% by weight of agent A in the cement composition.

次にB剤についてはこれはユージノール及びオ
リブ油からなり、ユージノールは50〜75重量%、
オリブ油は20〜40重量%が適当であり、有機脂肪
酸はその炭素数が10〜22で一般式CoH2o+1
COOH、CoH2o-1COOH、CoH2o-3COOH及びCo
H2o-5COOHの何れかに相当する有機飽和または
不飽和脂肪酸であり、その他プロピレングリコー
ル、ポリアルキレングリコールもB剤成分として
試用されることができる。さらにこれらのグリコ
ール化合物の混合物も使用され得る。
Next, regarding agent B, it consists of eugenol and olive oil, eugenol is 50 to 75% by weight,
The appropriate amount of olive oil is 20 to 40% by weight, and the organic fatty acid has 10 to 22 carbon atoms and has the general formula C o H 2o + 1.
COOH, C o H 2o-1 COOH, C o H 2o-3 COOH and C o
It is an organic saturated or unsaturated fatty acid corresponding to any of H 2o-5 COOH, and propylene glycol and polyalkylene glycol can also be used as the B agent component. Furthermore, mixtures of these glycol compounds may also be used.

ユージノール(オイゲノール)は丁字油の主成
分(通常70%以上を含む)であるが、日本薬局方
丁字油はユージノール及び関連化合物を含め総オ
イゲノールとして80%以上を含量規格としてい
る。本発明においてユージノールは上記局方丁字
油とはほとんど同一の物質とみなされて本発明の
製品を製することができる。
Eugenol is the main component of clove oil (usually containing 70% or more), but the Japanese Pharmacopoeia clove oil has a content standard of 80% or more as total eugenol, including eugenol and related compounds. In the present invention, eugenol is considered to be almost the same substance as the above-mentioned pharmacopoeia clove oil, and the product of the present invention can be manufactured.

以上本発明のセメント組成物の特異成分につい
て詳述したが該セメント組成物の製造は実施例に
示すように先ず仕込量のA剤各組成分を秤量しこ
れを粉砕した後に撹拌機で混和しほぼ一様の混和
物(粉体)にしてから製せられる。B剤はB剤組
成分を秤量したものを相互に混合して全体(液
体)が均一になれば充分である。使用時に術者は
A剤とB剤との適量をとり、練和して患部に対し
て使用する。
The specific components of the cement composition of the present invention have been described in detail above, but as shown in the examples, the cement composition is manufactured by first weighing the charged amount of each component of Agent A, pulverizing it, and then mixing it with a stirrer. It is manufactured after being made into a nearly uniform mixture (powder). For the B agent, it is sufficient that the components of the B agent are weighed and mixed together to make the whole (liquid) uniform. During use, the operator takes appropriate amounts of Agents A and B, mixes them together, and applies them to the affected area.

実施例 例 1 (A剤) (重量%) 酸化亜鉛 55 ロジン 25 ケイソイ土 15 パルプ繊維 4 CVP 1 (B剤) (重量%) 丁字油 75 オリプ油 24.5 プロピオン酸 0.5 ロジン塊を予め10メシユ程度に粉砕し、この粉
砕ロジン25Kg及び酸化亜鉛55Kgを混和して微粉砕
する。該粉砕物に対しケイソウ土15Kg、パルプ繊
維4Kg及びCVP1Kgを加えて緩速度で混合しA剤
を製した。B剤については丁字油75Kg、オリブ油
24.5Kg及びプロピオン酸0.5Kgを秤取し混合して
B剤を製した。
Example 1 (Part A) (Weight %) Zinc oxide 55 Rosin 25 Diatomaceous earth 15 Pulp fiber 4 CVP 1 (Part B) (Weight %) Clove oil 75 Olive oil 24.5 Propionic acid 0.5 The rosin lump was cut into about 10 mesh in advance. It is ground, and 25 kg of this ground rosin and 55 kg of zinc oxide are mixed and finely ground. 15 kg of diatomaceous earth, 4 kg of pulp fiber and 1 kg of CVP were added to the pulverized material and mixed at a slow speed to prepare Form A. For agent B, clove oil 75kg, olive oil
24.5 kg and propionic acid 0.5 kg were weighed out and mixed to prepare Form B.

本例の製品は歯科、口腔外科のみならず外科、
成形外科、獣医科等において好適に使用され得
る。
The product in this example is applicable not only to dentistry and oral surgery, but also to surgery.
It can be suitably used in plastic surgery, veterinary medicine, etc.

例 2 (A剤) (重量%) 酸化亜鉛 60 ロジン 25 ステアリン酸マグネシウム 7.8 パルプ繊維 7 CVP 0.2 (B剤) (重量%) 丁字油 65 オリブ油 35 例1に準じて酸化亜鉛60Kg及びロジン25Kgを混
和した粉砕物を製し、これに対しステアリン酸マ
グネシウム7.8Kg、パルプ繊維7Kg及びCVP0.2Kg
を加えてA剤を製した。
Example 2 (Part A) (% by weight) Zinc oxide 60 Rosin 25 Magnesium stearate 7.8 Pulp fiber 7 CVP 0.2 (Part B) (% by weight) Clove oil 65 Olive oil 35 According to Example 1, add 60 kg of zinc oxide and 25 kg of rosin. A mixed pulverized product was prepared, for which 7.8Kg of magnesium stearate, 7Kg of pulp fiber and 0.2Kg of CVP were added.
was added to prepare Form A.

B剤についても例1の方法に準じ、丁字油65Kg
及びオリブ油35Kgを混合しB剤を製した。
For agent B, follow the method of Example 1 and add 65 kg of clove oil.
and 35 kg of olive oil were mixed to prepare agent B.

例 3 (A剤) (重量%) 酸化亜鉛 55 ロジン 30 ケイソイ土 10 パルプ繊維 4 ステアリン酸 1 (B剤) (実量%) ユージノール 60 オリブ油 40 例1に準じて酸化亜鉛55Kg及びロジン30Kgを混
和した粉砕物を製し、これに対しケイソウ土10
Kg、パルプ繊維4Kg及びステアリン酸1Kgを加え
てA剤を製した。B剤についても例1の方法に準
じユージノール60Kg及びオリブ油40Kgを混合しB
剤を製した。
Example 3 (Part A) (% by weight) Zinc oxide 55 Rosin 30 Diatomaceous earth 10 Pulp fiber 4 Stearic acid 1 (Part B) (Actual amount %) Eugenol 60 Olive oil 40 According to Example 1, add 55 kg of zinc oxide and 30 kg of rosin. A mixed pulverized product is prepared, and 10% of diatomaceous earth is added to this.
1 kg, pulp fiber 4 kg and stearic acid 1 kg were added to prepare Form A. For agent B, 60 kg of eugenol and 40 kg of olive oil were mixed according to the method of Example 1.
A drug was prepared.

例 4 (A剤) (重量%) 酸化亜鉛 55 ロジン 20 ケイソイ土 20 パルプ繊維 4.5 CVP 0.5 (B剤) (重量%) リノール酸 20 イソステアリン酸 30 プロピレングリコール 50 例1に準じて酸化亜鉛55Kg及びロジン20Kgを混
和した粉砕物を製し、これに対しケイソウ土20
Kg、パルプ繊維4.5Kg及びCVP0.5Kgを加えてA剤
を製した。B剤についても例1の方法に準じリー
ノール酸20Kg、イソステアリン酸30Kg及びプロピ
レングリコール50Kgを混合しB剤を製した。
Example 4 (Part A) (% by weight) Zinc oxide 55 Rosin 20 Diatomaceous earth 20 Pulp fiber 4.5 CVP 0.5 (Part B) (% by weight) Linoleic acid 20 Isostearic acid 30 Propylene glycol 50 55 kg of zinc oxide and rosin according to Example 1 A pulverized product is prepared by mixing 20 kg of diatomaceous earth, and 20 kg of diatomaceous earth
Kg, pulp fiber 4.5Kg and CVP 0.5Kg were added to prepare A agent. A B agent was prepared by mixing 20 kg of linoleic acid, 30 kg of isostearic acid, and 50 kg of propylene glycol in the same manner as in Example 1.

例 5 (A剤) (重量%) 酸化亜鉛 40 ロジン 40 ケイソイ土 12 パルプ繊維 5 CVP 3 (B剤) (重量%) リノール酸 50 プロピレングリコール 50 例1に準じて酸化亜鉛40Kg及びロジン40Kgを混
和した粉砕物を製し、これに対しケイソウ土12
Kg、パルプ繊維5Kg及びCVP3Kgを加えてA剤を
製した。B剤についてはリノール酸50Kg及びプロ
ピレングリコール50Kgを秤取し混合してB剤を製
した。
Example 5 (Part A) (% by weight) Zinc oxide 40 Rosin 40 Diatomaceous earth 12 Pulp fiber 5 CVP 3 (Part B) (% by weight) Linoleic acid 50 Propylene glycol 50 Mix 40 kg of zinc oxide and 40 kg of rosin according to Example 1 12 diatomaceous earth
Kg, pulp fiber 5Kg and CVP 3Kg were added to prepare A agent. Regarding B agent, 50 kg of linoleic acid and 50 kg of propylene glycol were weighed out and mixed to prepare B agent.

例 6 (A剤) (重量%) 酸化亜鉛 50 ロジン 28 ケイソイ土 15 パルプ繊維 5 CVP 1 ミリスチン酸 1 (B剤) (重量%) ユージノール 65 オリブ油 34.5 プロピオン酸 0.5 例1に準じて酸化亜鉛50Kg及びロジン28Kgを混
和した粉砕物を製し、これに対しケイソウ土15
Kg、パルプ繊維5Kg、CVP1Kg及びミリスチン酸
1Kgを加えてA剤を製した。
Example 6 (Part A) (Weight%) Zinc oxide 50 Rosin 28 Diatomaceous earth 15 Pulp fiber 5 CVP 1 Myristic acid 1 (Part B) (Weight%) Eugenol 65 Olive oil 34.5 Propionic acid 0.5 Zinc oxide 50Kg according to Example 1 A crushed product was prepared by mixing 28 kg of rosin and 15 kg of diatomaceous earth.
1 kg of pulp fiber, 1 kg of CVP, and 1 kg of myristic acid to prepare Form A.

B剤についても例1の方法に準じ、ユージノー
ル65Kg、オリブ油34.5Kg及びプロピオン酸0.5Kg
を混合しB剤を製した。
For agent B, the method of Example 1 was followed, including 65 kg of eugenol, 34.5 kg of olive oil, and 0.5 kg of propionic acid.
were mixed to prepare Form B.

発明の効果 以上の各実施例において製造されたA剤(散
剤)及びB剤(液剤)を適量ずつ練和して得られ
る練和物は口腔内のみならず外科、成形外科、獣
医科等の他の領域における湿潤した創傷面に付着
しやすく、セメント体(硬化物)は長時間局所に
安定して滞留することにより、創傷面の保護に十
分な効果を奏することが期待される。
Effects of the Invention The mixture obtained by kneading appropriate amounts of Agent A (powder) and Agent B (liquid) produced in each of the above Examples can be used not only in the oral cavity but also in surgery, plastic surgery, veterinary medicine, etc. It easily adheres to moist wound surfaces in other areas, and the cement body (hardened material) is expected to be sufficiently effective in protecting the wound surface by stably staying locally for a long time.

又本製剤の組成物中にはアスベストを含まない
ため人体への安全性も高い。又本発明のセメント
組成物はその製造が容易で製品コストも低廉であ
る。
Furthermore, since the composition of this preparation does not contain asbestos, it is highly safe for the human body. Furthermore, the cement composition of the present invention is easy to manufacture and the product cost is low.

Claims (1)

【特許請求の範囲】 1 酸化亜鉛35〜60重量%、ロジン20〜40重量
%、ケイソウ土10〜20重量%、ガルボキシビニル
ポリマー及び(又は)有機脂肪酸0.1〜3.0重量%
及びパルプ繊維2〜7重量%を含有するA剤と、
ユージノールは丁字油;一般式CoH2o+1COOH
(式中nは10〜22の整数を示す)で表される有機
飽和脂肪酸;CoH2o-1COOH、CoH2o-3COOH又
はCoH2o-5COOH(式中nは10〜22の整数を示す)
のいずれかで表される有機不飽和脂肪酸;プロピ
レングリコール、ポリアルキレングリコール、又
はこれらのグリコール化合物の混合物;及びオリ
ブ油からなる群から選ばれる少なくとも1種の成
分を含有するB剤とからなる組成物であること、
及び該A剤に対しB剤を加えて練合わせた練和物
がセメント化することを特徴とするセメント組成
物。 2 カルボキシビニルポリマーがアクリル酸とア
リル化多価アルコールとの共重合体である特許請
求の範囲第1項記載のセメント組成物。 3 A剤中の有機脂肪酸が一般式CoH2oCOOHで
表わされる有機飽和脂肪酸(式中nは10〜22の整
数を示す)である特許請求の範囲第1項記載のセ
メント組成物。 4 A剤中の有機脂肪酸がラウリン酸、ミリスチ
ン酸、パルミチン酸及びステアリン酸からなる群
から選ばれる少なくとも1種の化合物である特許
請求の範囲第3項記載のセメント組成物。
[Claims] 1. 35-60% by weight of zinc oxide, 20-40% by weight of rosin, 10-20% by weight of diatomaceous earth, 0.1-3.0% by weight of galboxyvinyl polymer and/or organic fatty acid.
and A agent containing 2 to 7% by weight of pulp fiber,
Eugenol is clove oil; general formula C o H 2o+1 COOH
Organic saturated fatty acids represented by C o H 2o-1 COOH, C o H 2o-3 COOH or C o H 2o-5 COOH (in the formula, n is an integer of 10 to 22); ~22 integers)
A composition consisting of an organic unsaturated fatty acid represented by any one of; propylene glycol, polyalkylene glycol, or a mixture of these glycol compounds; and agent B containing at least one component selected from the group consisting of olive oil. being a thing,
and a cement composition characterized in that a mixture obtained by adding agent B to agent A and kneading the mixture becomes cement. 2. The cement composition according to claim 1, wherein the carboxyvinyl polymer is a copolymer of acrylic acid and allylated polyhydric alcohol. 3. The cement composition according to claim 1, wherein the organic fatty acid in agent A is an organic saturated fatty acid represented by the general formula C o H 2o COOH (in the formula, n represents an integer of 10 to 22). 4. The cement composition according to claim 3, wherein the organic fatty acid in agent A is at least one compound selected from the group consisting of lauric acid, myristic acid, palmitic acid, and stearic acid.
JP60231998A 1985-10-17 1985-10-17 Cement composition Granted JPS6291447A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60231998A JPS6291447A (en) 1985-10-17 1985-10-17 Cement composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60231998A JPS6291447A (en) 1985-10-17 1985-10-17 Cement composition

Publications (2)

Publication Number Publication Date
JPS6291447A JPS6291447A (en) 1987-04-25
JPH0414583B2 true JPH0414583B2 (en) 1992-03-13

Family

ID=16932340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60231998A Granted JPS6291447A (en) 1985-10-17 1985-10-17 Cement composition

Country Status (1)

Country Link
JP (1) JPS6291447A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753645B2 (en) * 1990-02-15 1995-06-07 日本油脂株式会社 Dental cement hardening liquid
KR20090098783A (en) * 2006-09-21 2009-09-17 토시키 오구로 Hard tissue regeneration accelerator
JP5280801B2 (en) * 2008-10-30 2013-09-04 株式会社ビーブランド・メディコーデンタル Dental composition

Also Published As

Publication number Publication date
JPS6291447A (en) 1987-04-25

Similar Documents

Publication Publication Date Title
Bakhtiar et al. Human pulp responses to partial pulpotomy treatment with TheraCal as compared with Biodentine and ProRoot MTA: a clinical trial
US5362495A (en) Insert material for widening the gingival sulcus
US4657592A (en) Root canal sealer
US3219527A (en) Peridontal pack or dressing composition
AT15430U1 (en) Dental agent based on hyaluronan and octenidine dihydrochloride
Plotino et al. Complications due to root canal filling procedures
Johnson Root canal filling materials
JPH0414583B2 (en)
EP2638892A1 (en) Bioactive hydraulic organic matrix materials
JPS5940131B2 (en) Pulpless dental treatment paste
JP3473879B2 (en) Dental root canal filling composition
US20190298621A1 (en) Methods of treatment of the dental pulp and filling root canals using anti inflammatory rinse solution and filling composition
JP5439642B2 (en) Bactericidal root canal sealer and preparation kit
US20190008729A1 (en) Dental composition and method of direct pulp capping
GB2131293A (en) Composition containing dextran for use in medical treatment
El Tawil et al. Sealing ability of MTA versus Portland cement in the repair of furcal perforations of primary molars: A dye extraction leakage model
JPS60181004A (en) Dental cement composition
JP4132809B2 (en) Glass ionomer sealer composition for root canal filling
US1900237A (en) Dental cement and process of making dental cement
JPH0585914A (en) Curing type paste material
SU833238A1 (en) Composition for treating parodontosis
JPH0468281B2 (en)
RU2846893C1 (en) Dental product for formation of endodontic cement
JPH04230612A (en) Curing type paste for filling in root canal
JPH02200624A (en) Dental dressing agent

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees